UY33542A - USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSIS - Google Patents
USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSISInfo
- Publication number
- UY33542A UY33542A UY0001033542A UY33542A UY33542A UY 33542 A UY33542 A UY 33542A UY 0001033542 A UY0001033542 A UY 0001033542A UY 33542 A UY33542 A UY 33542A UY 33542 A UY33542 A UY 33542A
- Authority
- UY
- Uruguay
- Prior art keywords
- teriflunomide
- multiple sclerosis
- treat multiple
- treat
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Esta invención se refiere al uso de teriflunomida para el tratamiento de la Esclerosis Múltiple(EM) y para tratar los riesgos asociados con el uso de teriflunomida.This invention relates to the use of teriflunomide for the treatment of Multiple Sclerosis (MS) and to treat the risks associated with the use of teriflunomide.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36978010P | 2010-08-02 | 2010-08-02 | |
US36977910P | 2010-08-02 | 2010-08-02 | |
US38937510P | 2010-10-04 | 2010-10-04 | |
US201061424717P | 2010-12-20 | 2010-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY33542A true UY33542A (en) | 2012-02-29 |
Family
ID=45559773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001033542A UY33542A (en) | 2010-08-02 | 2011-08-02 | USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSIS |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2600861A1 (en) |
AR (1) | AR082436A1 (en) |
UY (1) | UY33542A (en) |
WO (1) | WO2012018704A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2762135A1 (en) * | 2013-02-04 | 2014-08-06 | Sanofi | Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients |
JOP20190207A1 (en) | 2017-03-14 | 2019-09-10 | Actelion Pharmaceuticals Ltd | Pharmaceutical combination comprising ponesimod |
AU2021253674A1 (en) * | 2020-04-09 | 2022-11-03 | Novartis Ag | Ofatumumab for treating MS while maintaining serum IgG |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268382A (en) | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
GB0123571D0 (en) | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
-
2011
- 2011-08-01 WO PCT/US2011/046076 patent/WO2012018704A1/en active Application Filing
- 2011-08-01 AR ARP110102772A patent/AR082436A1/en unknown
- 2011-08-01 EP EP11746365.3A patent/EP2600861A1/en not_active Ceased
- 2011-08-02 UY UY0001033542A patent/UY33542A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2600861A1 (en) | 2013-06-12 |
AR082436A1 (en) | 2012-12-05 |
WO2012018704A1 (en) | 2012-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20130550A (en) | CYCLOPROPILAMINS AS INHIBITORS OF DEMETHYLASE 1 SPECIFIC TO LISINA | |
ECSP14017269A (en) | COMPOUNDS TO TREAT SPINAL MUSCULAR ATROPHY | |
ECSP15026557A (en) | COMPOUNDS AND THEIR METHODS OF USE | |
MX2013015311A (en) | Pcsk9-binding polypeptides and methods of use. | |
GT201400057A (en) | 3-PIRMIDIN-4-IL-OXAZOLIDIN-2-ONAS AS INHIBITORS OF THE MUTANT HDI | |
CL2012003385A1 (en) | Incontinence treatment. | |
CR20130045A (en) | THERAPEUTIC COMPOUNDS | |
ECSP13012786A (en) | ANTI-PCSK9 ANTIBODIES AND METHODS OF USE | |
EA201270619A1 (en) | USE OF BETANEHOL FOR THE TREATMENT OF XEROSTOMY | |
AR089993A1 (en) | PEPTIDOMIMETIC MACROCICLES | |
CL2013000675A1 (en) | Compounds derived from substituted pyrazolamide, with activity on pge2 / ep4; pharmaceutical composition that includes them; and its use for the treatment of multiple sclerosis and rheumatoid arthritis. | |
UY34037A (en) | NEW USEFUL COMPOUND FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES. | |
RS53893B1 (en) | Use of biotin for the treatment of multiple sclerosis | |
DOP2014000098A (en) | 2-THIOPIRIMIDINONES | |
IN2014CN04014A (en) | ||
CO6410315A2 (en) | NEW ANTI-ALFA5BETA1 ANTIBODIES AND THEIR USES | |
CL2015000976A1 (en) | Compounds of 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine for use in the treatment of diabetes and its associated disorders. | |
UY34616A (en) | NEW USEFUL COMPOUND FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES. | |
UY34315A (en) | ? USE OF AN AROMATASE INHIBITOR FOR THE TREATMENT OF HYPOGONADISM AND RELATED DISEASES? | |
BR112014000634A2 (en) | Methods for treating incontinence associated with sexual activity | |
BR112014009456A2 (en) | use of melatonin for the treatment and / or prevention of mucositis | |
UY33542A (en) | USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSIS | |
CR20130138A (en) | PROCESS FOR THE PREPARATION OF PAN-CDK INHIBITORS OF THE FORMULA (I), AND INTERMEDIARIES OF THE PREPARATION | |
CR20150159A (en) | OXAZOLIDINONA 3,4-DISPOSED DERIVATIVES AND THEIR USE AS INHIBITORS OF POTASSIUM CALCIUM ACTIVATED | |
AR081220A1 (en) | USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY |